Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic LeukemiaJohn C. Byrd, Richard R. Furman, Susan O’Brien et al.|New England Journal of Medicine|2015Cited by 890
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin LymphomaBonnie K. Harrington, William C. Kisseberth|PLoS ONE|2016Cited by 58